6I3U: PDB entry 6I3U

Optimization of potent and selective ATM inhibitors suitable for a proof-of-concept study in Huntington's disease models. Determined by X-ray diffraction at 2.09 Å resolution. Released 20 Mar 2019.

Method
X-ray diffraction
Resolution
2.09 Å
Organism
Homo sapiens
Chains
1
Atoms
4,634
Mol. weight
70.64 kDa
Ligands
H2E
Released
20 Mar 2019

Explore 6I3U in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

6I3U contains 37 α-helices and 12 β-strands across 1 chain. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 37 helices, 12 β-strands

ElementResiduesLengthSheet
α-helix275-2784
α-helix281-2833
α-helix290-30112
α-helix306-3094
α-helix310-3189
α-helix320-3234
α-helix327-3293
α-helix330-3356
α-helix342-35413
α-helix356-3594
α-helix360-3634
α-helix364-3674
α-helix374-38411
α-helix389-40214
α-helix403-4053
α-helix408-4125
α-helix442-4443
α-helix475-48511
α-helix487-50216
α-helix504-5096
α-helix511-53020
α-helix533-56028
α-helix566-57813
α-helix580-5834
β-strand591-59331
β-strand596-60491
α-helix606-6083
β-strand610-61121
β-strand619-62571
β-strand630-63781
α-helix642-66019
β-strand672-67431
β-strand679-68351
β-strand689-69022
α-helix691-6988
α-helix701-7088
β-strand71013
α-helix715-7173
β-strand71813
α-helix720-74021
β-strand750-75232
β-strand758-76032
α-helix782-7876
α-helix794-81118
α-helix814-8229
α-helix830-8334
α-helix836-8383
α-helix839-8468
α-helix853-87119

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Phosphatidylinositol 3-kinase catalytic subunit type 3Aprotein615Homo sapiensQ8NEB9 (AlphaFold model)
Sequence of entity 1 (A), FASTA
>6I3U_1 Phosphatidylinositol 3-kinase catalytic subunit type 3 (chains A)
SMSKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTN
QEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLR
QADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQI
ITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQD
TQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGN
RKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLAKSANMPAQLFFKT
EDGGKYPVLFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFLQWI
QGSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDR
HLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYT
AFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLID
ESVHALFAAVVEQIH

Ligands and cofactors

IDNameFormulaCopies
H2E2-morpholin-4-yl-6-[7-[(2~{R})-1-morpholin-4-ylpropan-2-yl]oxy-9~{H}-thioxanthe…C29 H32 N2 O5 S1

Primary citation

Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models. Toledo-Sherman, L., Breccia, P., Cachope, R. et al. J Med Chem (2019) 62:2988-3008. DOI 10.1021/acs.jmedchem.8b01819 · PubMed

Other PDB entries of the same protein (UniProt Q8NEB9 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 6I3U directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.